Role of Exercise in PRISm and Subsequent Development of COPD
Role of Exercise in Functional Capacity of Smokers and Subsequent Development of Chronic Obstructive Pulmonary Disease
1 other identifier
interventional
90
1 country
1
Brief Summary
Preserved Ratio Impaired Spirometry (PRISm) describes individual with spirometry findings of forced expiratory volume (FEV1) and forced vital capacity (FVC) ratio greater than 0.7 but with the FEV1 less than 80% predicted. While the spirometry findings of individuals with PRISm can be transited into obstructive pattern, remains at PRISm or become normal spirometry, limited evidence is on the role of exercise in the course of PRISm. This study aims to investigate the role of exercise, namely exercise with telehealth and walking exercise, together with smoking cessation advice, would alter the clinical course of PRISm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2025
CompletedFirst Submitted
Initial submission to the registry
January 27, 2026
CompletedFirst Posted
Study publicly available on registry
February 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
March 6, 2026
January 1, 2026
1.5 years
January 27, 2026
March 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in 6 minute walk test distance
The 6 minute walk test distance will be measured in the start of the study, at 3 months, 6 months and 12 months. The differences will be compared.
1 year
Study Arms (3)
Exercise with telehealth group
EXPERIMENTALParticipants will attend telehealth physiotherapy class for exercise. Smoking cessation advice will be given.
Exercise group
ACTIVE COMPARATORParticipants will exercise with walking. Smoking cessation advice will be given.
No exercise group
ACTIVE COMPARATORNo exercise instruction will be given. Participants are encouraged to exercise. Smoking cessation advice will be given.
Interventions
No exercise instruction will be given. Participants are encouraged to exercise. Smoking cessation advice will be given.
Participants will attend telehealth physiotherapy class for exercise. Smoking cessation advice will be given.
Participants will exercise with walking. Smoking cessation advice will be given.
Eligibility Criteria
You may qualify if:
- Age 18 or above
- Smoker/ ex-smoker
- Spirometry shows PRISm, with FEV1/FVC \>= 0.7 and FEV1 \<80% predicted
- Ambulatory to walk
- Able to give informed consent
You may not qualify if:
- Age below 18
- Non-smoker
- Spirometry does not show PRISm/ unable to perform spirometry
- Requires assistance for walking
- Unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Queen Mary Hospital, Hong Kongcollaborator
Study Sites (1)
The University of Hong Kong, Queen Mary Hospital
Hong Kong, China
Related Publications (4)
Hansen H, Bieler T, Beyer N, Kallemose T, Wilcke JT, Ostergaard LM, Frost Andeassen H, Martinez G, Lavesen M, Frolich A, Godtfredsen NS. Supervised pulmonary tele-rehabilitation versus pulmonary rehabilitation in severe COPD: a randomised multicentre trial. Thorax. 2020 May;75(5):413-421. doi: 10.1136/thoraxjnl-2019-214246. Epub 2020 Mar 30.
PMID: 32229541BACKGROUNDWan ES, Balte P, Schwartz JE, Bhatt SP, Cassano PA, Couper D, Daviglus ML, Dransfield MT, Gharib SA, Jacobs DR Jr, Kalhan R, London SJ, Navas-Acien A, O'Connor GT, Sanders JL, Smith BM, White W, Yende S, Oelsner EC. Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults. JAMA. 2021 Dec 14;326(22):2287-2298. doi: 10.1001/jama.2021.20939.
PMID: 34905031BACKGROUNDPerez-Padilla R, Montes de Oca M, Thirion-Romero I, Wehrmeister FC, Lopez MV, Valdivia G, Jardim JR, Muino A, B Menezes AM; PLATINO Group. Trajectories of Spirometric Patterns, Obstructive and PRISm, in a Population-Based Cohort in Latin America. Int J Chron Obstruct Pulmon Dis. 2023 Jun 21;18:1277-1285. doi: 10.2147/COPD.S406208. eCollection 2023.
PMID: 37366430BACKGROUNDHolland AE, Cox NS, Houchen-Wolloff L, Rochester CL, Garvey C, ZuWallack R, Nici L, Limberg T, Lareau SC, Yawn BP, Galwicki M, Troosters T, Steiner M, Casaburi R, Clini E, Goldstein RS, Singh SJ. Defining Modern Pulmonary Rehabilitation. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2021 May;18(5):e12-e29. doi: 10.1513/AnnalsATS.202102-146ST.
PMID: 33929307BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
King Pui Florence Chan, MD
he University of Hong Kong, Queen Mary Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2026
First Posted
February 4, 2026
Study Start
July 14, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
March 6, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
According to the current ethics approval protocol, the IPD will be stored anonymously and destroyed 3 years after completion of study.